Nilotinib for First-line Newly Diagnosed CML-CP Patients
Conditions: Chronic Myeloid Leukemia, Chronic Phase; Nilotinib Intervention: Drug: Nilotinib Sponsor: Shenzhen Second People's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials